AI assistant
USCOM LIMITED — Capital/Financing Update 2011
Feb 16, 2011
65979_rns_2011-02-16_472c2b29-4641-4d49-8a88-c39449aee2f5.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
Uscom Limited ABN 35 091 028 090 Suite 1, Level 7, 10 Loftus Street Sydney NSW 2000 Australia T +612 9247 4144 F +612 9247 8157 www.uscom.com.au
M A R K E T A N N O U N C E M E N T
Uscom completes Share purchase plan
Thursday 17th of February, 2011: Uscom (ASX code: UCM) today informed shareholders that is had completed the recent SPP.
The SPP closed on Friday the 11[th] of February 2011 and the company had received cleared SPP application funds of $264,781.80. A total of 882,606 shares will be allotted and issued to applicants on the 18[th] of February 2011.
The SPP follows the private placement completed in December 2010.
About Uscom
Uscom Limited is an Australian medical device company which was first listed on the Australian Stock Exchange in December 2003. Uscom has developed a Non Invasive Cardiac Output Monitor. The USCOM is a simple, cost-effective and non-invasive device that measures heart function, detects irregularities and guides treatment. The USCOM device has major applications in Paediatrics, Emergency Medicine, Intensive Care Units and Anesthesia, and is a tool of choice for management of adult and paediatric sepsis, and for the guidance of all fluid administration. USCOM has global regulatory approval and the technology is currently marketed in North America, South America, Europe, the Middle East, India, Australia & New Zealand. China and SE Asia.
Uscom Contacts Phil Kiely Executive Chairman [email protected]
Daniel Fah Company Secretary [email protected]